Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DUT | P33316 | 2/20 | 0.46 |
| ▸ | P2RY2 | P41231 | 10/20 | 0.44 |
| ▸ | P2RY4 | P51582 | 5/20 | 0.43 |
| ▸ | P2RY6 | Q15077 | 7/20 | 0.43 |
| ▸ | POLA1 | P09884 | 1/20 | 0.41 |
| ▸ | P2RY14 | Q15391 | 2/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2811539 | 0.88 | DUT (0.47) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL29431049 | 0.80 | DUT (0.56) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL7906610 | 0.80 | P2RY2 (0.52) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL3226919 | 0.80 | DUT (0.51) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL7906606 | 0.80 | P2RY2 (0.52) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL3393008 | 0.79 | DUT (0.48) | DUTP2RY2P2RY4P2RY6 | |
| SCHEMBL2811543 | 0.78 | DUT (0.61) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL95679 | 0.78 | P2RY2 (0.44) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL4348233 | 0.75 | P2RY2 (0.51) | DUTP2RY2P2RY4P2RY6POLA1 | |
| SCHEMBL1129230 | 0.74 | DUT (0.54) | DUTP2RY2P2RY4P2RY6POLA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120308987-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENVAULT CORPORATION (US) | 2012-12-06 | — | — | US | claimed |
| US-8283165-B2 | Matrices and media for storage and stabilization of biomolecules | GENVAULT CORPORATION (US) | 2012-10-09 | — | — | US | claimed |
| US-20100248363-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENVAULT CORPORATION (US) | 2010-09-30 | — | — | US | claimed |
| WO-2025109302-A2 | IN VITRO TRANSCRIPTION METHOD | THE UNIVERSITY OF SHEFFIELD (GB) | 2025-05-30 | — | — | WO | disclosed |
| US-20230384188-A1 | ROOM TEMPERATURE STABLE, DRY BIOLOGICAL TRANSPORT MEDIA | GENTEGRA, LLC | 2023-11-30 | — | — | US | disclosed |
| US-11827926-B2 | Methods and compositions for the diagnosis and treatment of COVID 19 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2023-11-28 | — | — | US | disclosed |
| US-20230374563-A1 | Methods for Antimicrobial Susceptibility Testing | MICROBEDX, INC. | 2023-11-23 | — | — | US | disclosed |
| US-20230365960-A1 | Methods for Lysis of Cells Within a Sample | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2023-11-16 | — | — | US | disclosed |
| US-20230265484-A1 | MULTIPLEXED METHODS FOR DETECTING TARGET RNAS | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2023-08-24 | — | — | US | disclosed |
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | NATURE'S TOOLBOX, INC. | 2022-09-01 | — | — | US | disclosed |
| US-20210310060-A1 | METHODS AND COMPOSITIONS FOR THE DIAGNOSIS AND TREATMENT OF COVID 19 | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2021-10-07 | — | — | US | disclosed |
| US-9840731-B2 | Preservation of biological materials in non-aqueous fluid media | GENTEGRA, LLC (US) | 2017-12-12 | — | — | US | disclosed |
| US-20170145477-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENTEGRA LLC (US) | 2017-05-25 | — | — | US | disclosed |
| US-9637513-B2 | Matrices and media for storage and stabilization of biomolecules | GENTEGRA LLC (US) | 2017-05-02 | — | — | US | disclosed |
| US-20150267245-A1 | PRESERVATION OF BIOLOGICAL MATERIALS IN NON-AQUEOUS FLUID MEDIA | GENTEGRA, LLC (US) | 2015-09-24 | — | — | US | disclosed |
| US-20150158902-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENTEGRA LLC (US) | 2015-06-11 | — | — | US | disclosed |
| US-8951719-B2 | Matrices and media for storage and stabilization of biomolecules | Gentegra, LLC. (US) | 2015-02-10 | — | — | US | disclosed |
| US-20120308987-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENVAULT CORPORATION (US) | 2012-12-06 | — | — | US | disclosed |
| US-8283165-B2 | Matrices and media for storage and stabilization of biomolecules | GENVAULT CORPORATION (US) | 2012-10-09 | — | — | US | disclosed |
| US-20100248363-A1 | MATRICES AND MEDIA FOR STORAGE AND STABILIZATION OF BIOMOLECULES | GENVAULT CORPORATION (US) | 2010-09-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220275028-A1 | Systems, Methods And Compositions For Recombinant In Vitro Transcription And Translation Utilizing Thermophilic Proteins | MRPL21, RNGTT, MRPS23 | DUT 984/4885P2RY2 4688/4885P2RY4 4823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.